| dc.date.accessioned | 2015-01-19T13:47:48Z | |
| dc.date.available | 2015-01-19T13:47:48Z | |
| dc.date.issued | 2010-09-10 | |
| dc.identifier.citation | Lalatsa , A Sept. 10 2010 , Oral Delivery of Hydrophilic Drugs to the Brain , Patent No. WO/2010/100479 . < http://patentscope.wipo.int/search/en/detail.jsf?docId=WO2010100479&recNum=1&maxRec=1&office=&prevFilter=&sortOption=&queryString=FP%3A%28lalatsa%29&tab=PCT+Biblio > | |
| dc.identifier.other | PURE: 1269889 | |
| dc.identifier.other | PURE UUID: 5c403fcb-44b4-44a5-8d5a-d67779e92e60 | |
| dc.identifier.uri | http://hdl.handle.net/2299/15242 | |
| dc.description.abstract | A composition comprising a lipophilic derivative of a hydrophilic drug and an amphiphile compound for use in therapy wherein the composition is orally administered to the human or animal body. The invention includes derivatives such as palmitoylated Leucine[5]-Enkephalin and is useful in the treatment of schizophrenia, obsesity, pain and sleep disorders, psychiatric diseases, neurodegenerative conditions, brain cancers and infective diseases. | en |
| dc.language.iso | eng | |
| dc.subject.classification | A61K 47/18 (2006.01), A61K 47/36 (2006.01), A61K 47/48 (2006.01) | |
| dc.title | Oral Delivery of Hydrophilic Drugs to the Brain | en |
| dc.contributor.institution | Centre for Research into Topical Drug Delivery and Toxicology | |
| dc.contributor.institution | Nanopharmaceutics | |
| dc.contributor.institution | Pharmaceutics | |
| dc.contributor.institution | Department of Pharmacy | |
| dc.contributor.institution | School of Life and Medical Sciences | |
| dc.contributor.institution | Health & Human Sciences Research Institute | |
| dc.contributor.inventor | Lalatsa, Aikaterini | |
| dc.identifier.url | http://patentscope.wipo.int/search/en/detail.jsf?docId=WO2010100479&recNum=1&maxRec=1&office=&prevFilter=&sortOption=&queryString=FP%3A%28lalatsa%29&tab=PCT+Biblio | |
| rioxxterms.type | Other | |
| herts.preservation.rarelyaccessed | true | |
